Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Shares Rise on Strong Q3 Results

Shares in Beckman Coulter rose 5.6 percent for the trading week ended Tuesday to lead all stocks in the BCW Index. The firm’s shares rose after it reported a 6.3-percent rise in revenue and 31-percent spike in net income for the third quarter. Shares in Bio-Rad Laboratories rose 4 percent for the week after it posted strong Q3 results.
 
Only four companies in the Index lost ground for the tracking period. Agilent led decliners with a drop of 5.5 percent. During the week, Agilent completed the spin-off of Verigy.
 
Overall, the Index rose 2 percent, beating the Nasdaq Biotech Index, which gained 1.4 percent. The broader Nasdaq market rose .4 percent for the week, while the Dow Jones Industrial Average closed up .6 percent.
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 7, 2006)
Last
Price
(October 31, 2006)
% change
Agilent
A
33.63 35.60 -5.5
Applied Biosystems
ABI
38.20 37.30 2.4
Beckman
BEC
60.82 57.57 5.6
Bio-Rad
BIO
76.38 73.42 4.0
Bruker
BRKR
7.87 7.96 -1.1
Fisher Scientific
FSH
88.70 85.62 3.6
GE
GE
35.54 35.11 1.2
Invitrogen
IVGN
57.38 58.01 -1.1
Millipore
MIL
66.78 64.53 3.5
Molecular Devices
MDCC
20.00 20.14 -0.7
PerkinElmer
PKI
21.70 21.36 1.6
Qiagen
QGEN
15.99 15.81 1.1
Sigma
SIAL
76.16 75.11 1.4
Stratagene
STGN
6.83 6.83 0.0
Thermo
TMO
44.36 42.87 3.5
Waters
WAT
50.52 49.80 1.4
BCW Index Average 43.80 42.94 2.0

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more